Paper36099501
Low Thrombin Generation in Users of a Contraceptive Containing Estetrol and Drospirenone.
Morimont L and 5 others. J Clin Endocrinol Metab, 2022. Cited by 32 papers, by iCite.
Cite this record
ConductScience Library. Low Thrombin Generation in Users of a Contraceptive Containing Estetrol and Drospirenone. Papers, record 36099501. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36099501
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Low Thrombin Generation in Users of a Contraceptive Containing Estetrol and Drospirenone.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Estetrol | Major topic |
| Thrombin | Major topic |
| Female | |
| Humans | |
| Contraceptives, Oral, Combined | |
| Ethinyl Estradiol | |
| Levonorgestrel | |
| Androstenes |
Source PubMed
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32538188 | Drospirenone 4 mg-only pill (DOP) in 24+4 regimen: a new option for oral contraception. | Expert Rev Clin Pharmacol | 2020 | https://conductscience.org/library/papers/32538188 | PubMed |
| 2 | 18462934 | Estetrol: a unique steroid in human pregnancy. | J Steroid Biochem Mol Biol | 2008 | https://conductscience.org/library/papers/18462934 | PubMed |
| 3 | 29936403 | Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis. | Thromb Res | 2018 | https://conductscience.org/library/papers/29936403 | PubMed |
| 4 | 18064335 | Effect of oral contraceptives on thrombin generation measured via calibrated automated thrombography. | Thromb Haemost | 2007 | https://conductscience.org/library/papers/18064335 | PubMed |
| 5 | 17080211 | Use of calibrated automated thrombinography +/- thrombomodulin to recognise the prothrombotic phenotype. | Thromb Haemost | 2006 | https://conductscience.org/library/papers/17080211 | PubMed |
| 6 | 12853707 | Calibrated automated thrombin generation measurement in clotting plasma. | Pathophysiol Haemost Thromb | 2003 | https://conductscience.org/library/papers/12853707 | PubMed |
| 7 | 18248600 | Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. | J Thromb Haemost | 2008 | https://conductscience.org/library/papers/18248600 | PubMed |
| 8 | 31444961 | Validation and standardization of the ETP-based activated protein C resistance test for the clinical investigation of steroid contraceptives in women: an unmet clinical and regulatory need. | Clin Chem Lab Med | 2020 | https://conductscience.org/library/papers/31444961 | PubMed |
| 9 | 16868297 | Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation. | JAMA | 2006 | https://conductscience.org/library/papers/16868297 | PubMed |
| 10 | 8630312 | The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives. | Br J Obstet Gynaecol | 1996 | https://conductscience.org/library/papers/8630312 | PubMed |
| 11 | 17560633 | The endogenous thrombin potential and the risk of venous thromboembolism. | Thromb Res | 2007 | https://conductscience.org/library/papers/17560633 | PubMed |
| 12 | 18948369 | Prediction of recurrent venous thromboembolism by endogenous thrombin potential and D-dimer. | Clin Chem | 2008 | https://conductscience.org/library/papers/18948369 | PubMed |
| 13 | 16287790 | Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. | Ann Intern Med | 2005 | https://conductscience.org/library/papers/16287790 | PubMed |
| 14 | 72289 | Haemostatic, lipid, and blood-pressure profiles of women on oral contraceptives containing 50 microgram or 30 microgram oestrogen. | Lancet | 1977 | https://conductscience.org/library/papers/72289 | PubMed |
| 15 | 35306927 | Profile of estetrol, a promising native estrogen for oral contraception and the relief of climacteric symptoms of menopause. | Expert Rev Clin Pharmacol | 2022 | https://conductscience.org/library/papers/35306927 | PubMed |
| 16 | 2960241 | Coagulation effects of oral contraception. | Am J Obstet Gynecol | 1987 | https://conductscience.org/library/papers/2960241 | PubMed |
| 17 | 32798963 | Letter to the Editors-in-Chief in response to the article of Abou-Ismail, et al. entitled "Estrogen and thrombosis: A bench to bedside review" (Thrombosis Research 192 (2020) 40-51). | Thromb Res | 2020 | https://conductscience.org/library/papers/32798963 | PubMed |
| 18 | 19679613 | Hormonal contraception and risk of venous thromboembolism: national follow-up study. | BMJ | 2009 | https://conductscience.org/library/papers/19679613 | PubMed |
| 19 | 34956081 | Combined Oral Contraceptives and Venous Thromboembolism: Review and Perspective to Mitigate the Risk. | Front Endocrinol (Lausanne) | 2021 | https://conductscience.org/library/papers/34956081 | PubMed |
| 20 | 23921878 | Norethindrone acetate 1.0 milligram and ethinyl estradiol 10 micrograms as an ultra low-dose oral contraceptive. | Obstet Gynecol | 2013 | https://conductscience.org/library/papers/23921878 | PubMed |
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42965049 | Signal of venous thromboembolism with ethinyl estradiol vs natural estrogens in oral contraceptives: analysis of the EudraVigilance and Food and Drug Administration Adverse Events Reporting System databases. | Res Pract Thromb Haemost | 2026 | https://conductscience.org/library/papers/42965049 | PubMed |
| 42724721 | Estetrol and its implications for contraception, venous thromboembolism, and breast cancer: an integrative review. | J Vasc Bras | 2026 | https://conductscience.org/library/papers/42724721 | PubMed |
| 42662895 | Effects of estetrol/drospirenone vs drospirenone-only on thrombin generation in women with polycystic ovary syndrome: a randomized, double-blind, controlled trial. | Res Pract Thromb Haemost | 2026 | https://conductscience.org/library/papers/42662895 | PubMed |
| 42568434 | Estetrol/drospirenone for combined oral contraception: a systematic review of efficacy, cycle control, and safety. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42568434 | PubMed |
| 41988925 | Estetrol-based combined oral contraceptives: A systematic review of clinical outcomes. | Acta Obstet Gynecol Scand | 2026 | https://conductscience.org/library/papers/41988925 | PubMed |
| 41970977 | A detailed review of pharmacokinetics/pharmacodynamics of progestogens in oral contraception. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/41970977 | PubMed |
| 41048432 | Chapter 3. Impact of estrogens on hemostasis. | Front Endocrinol (Lausanne) | 2025 | https://conductscience.org/library/papers/41048432 | PubMed |
| 40893655 | The impact of protein S and tissue factor pathway inhibitor on coagulation, assessed with thrombin generation, in women starting combined oral contraceptives. | Res Pract Thromb Haemost | 2025 | https://conductscience.org/library/papers/40893655 | PubMed |
| 40575268 | Cost-effective screening strategy to prevent venous thromboembolism in combined oral contraceptive users. | Front Endocrinol (Lausanne) | 2025 | https://conductscience.org/library/papers/40575268 | PubMed |
| 40568691 | Update on long- and short-acting contraceptive methods. | Aust Prescr | 2025 | https://conductscience.org/library/papers/40568691 | PubMed |
| 40200315 | The effect of combined oral contraceptives on thrombin generation assessed on ST Genesia- a paired clinical study. | Thromb J | 2025 | https://conductscience.org/library/papers/40200315 | PubMed |
| 39327996 | Impact of Estetrol Combined with Drospirenone on Blood Coagulation and Fibrinolysis in Patients with Endometriosis: A Multicenter, Randomized, Open-Label, Active-Controlled, Parallel-Group Study. | Clin Appl Thromb Hemost | 2024 | https://conductscience.org/library/papers/39327996 | PubMed |
| 39220361 | Are natural estrogens used in contraception at lower risk of venous thromboembolism than synthetic ones? A systematic literature review and meta-analysis. | Front Endocrinol (Lausanne) | 2024 | https://conductscience.org/library/papers/39220361 | PubMed |
| 37951241 | Proposal for targeted, neo-evolutionary-oriented secondary prevention of early-onset endometriosis and adenomyosis. Part II: medical interventions. | Hum Reprod | 2024 | https://conductscience.org/library/papers/37951241 | PubMed |
| 37854030 | The benefits of estetrol addition to drospirenone for contraception. | AJOG Glob Rep | 2023 | https://conductscience.org/library/papers/37854030 | PubMed |
| 37674929 | Response to paper by Binkowska et al. Risk of venous thromboembolism during the use of oral estrogen-progestogen hormone therapies in light of most recent research findings. Commentary: Oestradiol is not the holy grail in the quest for the ideal oestrogen therapy. | Prz Menopauzalny | 2023 | https://conductscience.org/library/papers/37674929 | PubMed |
| 37373625 | Estetrol Is Safe and Well Tolerated during Treatment of Hospitalized Men and Women with Moderate COVID-19 in a Randomized, Double-Blind Study. | J Clin Med | 2023 | https://conductscience.org/library/papers/37373625 | PubMed |
| 37133685 | Estetrol: From Preclinical to Clinical Pharmacology and Advances in the Understanding of the Molecular Mechanism of Action. | Drugs R D | 2023 | https://conductscience.org/library/papers/37133685 | PubMed |
Genes16
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36099501
GET https://conductscience.org/api/papers/v1/36099501/references?page=2